Christine Schmid-Tannwald to Retrospective Studies
This is a "connection" page, showing publications Christine Schmid-Tannwald has written about Retrospective Studies.
Connection Strength
0.810
-
Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients. Radiol Oncol. 2024 09 01; 58(3):348-356.
Score: 0.077
-
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors. Radiol Oncol. 2024 06 01; 58(2):196-205.
Score: 0.077
-
Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases. Radiol Oncol. 2024 03 01; 58(1):33-42.
Score: 0.076
-
Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM. Radiol Oncol. 2023 12 01; 57(4):436-445.
Score: 0.075
-
Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study. Acta Radiol. 2022 Jul; 63(7):877-888.
Score: 0.063
-
The role of diffusion-weighted MRI in assessment of inflammatory bowel disease. Abdom Radiol (NY). 2016 08; 41(8):1484-94.
Score: 0.045
-
Role of diffusion-weighted MRI in differentiation of hepatic abscesses from non-infected fluid collections. Clin Radiol. 2014 Jul; 69(7):687-94.
Score: 0.038
-
DW-MRI of liver lesions: can a single ADC-value represent the entire lesion? Clin Radiol. 2014 May; 69(5):492-8.
Score: 0.038
-
Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases? Acta Radiol. 2014 Jun; 55(5):515-23.
Score: 0.037
-
Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas. Eur J Nucl Med Mol Imaging. 2013 Jun; 40(6):897-907.
Score: 0.035
-
Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate. Acta Radiol. 2012 Nov 01; 53(9):961-5.
Score: 0.034
-
Diffusion-weighted MRI: role in detecting abdominopelvic internal fistulas and sinus tracts. J Magn Reson Imaging. 2012 Jan; 35(1):125-31.
Score: 0.032
-
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board. Target Oncol. 2025 Jul; 20(4):715-724.
Score: 0.021
-
[18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics. Eur J Nucl Med Mol Imaging. 2025 Nov; 52(13):5175-5188.
Score: 0.021
-
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. Theranostics. 2025; 15(13):6444-6453.
Score: 0.021
-
Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs. Cancer Imaging. 2023 Apr 25; 23(1):41.
Score: 0.018
-
Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma. Acta Radiol. 2024 Jan; 65(1):14-22.
Score: 0.018
-
Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans. Eur J Nucl Med Mol Imaging. 2016 Jun; 43(6):1105-14.
Score: 0.011
-
Magnetic resonance enterography/enteroclysis in acquired small bowel diverticulitis and small bowel diverticulosis. Eur Radiol. 2016 Sep; 26(9):2881-91.
Score: 0.011
-
Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability. Invest Radiol. 2015 Jan; 50(1):57-66.
Score: 0.010
-
Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma. J Nucl Med. 2015 Jan; 56(1):9-15.
Score: 0.010
-
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. J Nucl Med. 2014 Feb; 55(2):198-203.
Score: 0.009
-
Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology. 2013 Jun; 267(3):797-806.
Score: 0.009
-
Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. Radiology. 2013 Jun; 267(3):787-96.
Score: 0.009
-
Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol. 2011 Dec; 197(6):1382-90.
Score: 0.008
-
Diffusion-weighted MR imaging of abdominopelvic abscesses. Emerg Radiol. 2011 Dec; 18(6):515-24.
Score: 0.008